Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT03102502
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 110 participants
- Sponsor
- Registry
-
NCT03102502
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03102502. Randomized; single masking; primary purpose treatment. Start 2017-03-10 (actual); primary completion 2018-10-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status
- Acronym
- EECPVHS
- Condition
- Coronary Heart Disease
- Intervention (Device)
- EECP
- Intervention (Drug)
- Medical therapy
- Lead sponsor
- Sun Yat-sen University
Record details
- Record id
cardio:ct-nct03102502- Content hash
351a9f197aaeefc49d57e560707f02523d0edaa0246697acc174c177f1e687e2